BEIJING: Some experts said it was possible for China to approve a vaccine by the end of this year to meet the urgent need of some countries severely hit by the epidemic.

Brazil has gathered enough infection data from a late-stage trial of an experimental coronavirus disease 2019 (Covid-19) vaccine developed by China’s Sinovac Biotech (Sinovac) and expects to have interim results on its efficiency in the first week of December based on analysis of the data from an independent committee, Reuters reported Tuesday, citing trial organizers.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details